Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

NEW LGC AccuSet Syphilis Performance Panel

Products are for professional/laboratory use only.

Abacus dx is pleased to inform you about the NEW AccuSet™ Syphilis Performance Panel from LGC!

The AccuSet™ Syphilis Performance Panel 0820-0300 is intended for use by diagnostic manufacturers, researchers, and clinical laboratories to develop, evaluate, or troubleshoot syphilis test methods. Characterized samples and comprehensive data are provided for comparative analysis. For research use only. Not for use in diagnostic procedures.

This product is a 20-member syphilis performance panel. Panel members are undiluted, naturally-occurring plasma samples with reactivity ranging from negative to positive for non-treponemal reagins and treponemal antibodies. Each sample represents a single collection event. No preservatives were added

For more information about this panel please view the below Datasheet & Package Insert for your reference.

View the Package Insert >

Download Now >

View the Datasheet >

Download Now >

View the SeraCare Product Catalogue >

Download Now >

Request a quote

Contact Us Now >



Request a Quote

Request Quote

Recent Posts

Fungal Infection – Assays and Controls*

IMMY | Vircell IMMY’s rapid fungal assays and Vircell’s external controls deliver reliable, room temperature diagnostics with built-in quality assurance for streamlined serology workflows. Vircell…

Read full article

Vircell – VirClia Extraction Tube

Discover Vircell’s VirClia Extraction Tube, an innovative pre-dispensed tube featuring a one-step filtering process that eliminates the need for centrifugation, thereby significantly simplifying the pre-analytical…

Read full article

Advancing Sepsis Diagnostics—Journal of Clinical Medicine (JCM), Honors SeptiCyte RAPID* Study

  Immunexpress are delighted to announce that the study, “Validation of SeptiCyte® RAPID to Discriminate Sepsis from Non-Infectious Systemic Inflammation,” has been selected as an Editor’s Choice Paper for 2024 by the Journal of Clinical Medicine (JCM) MDPI Editorial Team. This honour…

Read full article